Market Overview

Benzinga's Volume Movers

Related CNAT
Company news for March 31, 2014 - Corporate Summary
US Stock Futures Signal Lower Start On Wall Street
Related GALT
Galectin Therapeutics Announces First Patient Dosed in Second Cohort of Phase 1 Trial of GR-MD-02 for NASH With Advanced Fibrosis; Exoects GR-MD-02 Phase 1 Cohort 2 Result at End of July
Galectin Therapeutics (GALT) Falls: Stock Goes Down 11.3% - Tale of the Tape

Conatus Pharmaceuticals (NASDAQ: CNAT) shares moved up 35.20% to $13.25 after jumping 57.05% on Thursday. The volume of Conatus Pharmaceuticals shares traded was 6786% higher than normal.

Galectin Therapeutics (NASDAQ: GALT) shares rose 21.19% to $16.35. The volume of Galectin Therapeutics shares traded was 3091% higher than normal. Galectin reported that it has sold 2.39 million shares at an average price of $9.99 per share.

Intercept Pharmaceuticals (NASDAQ: ICPT) shares climbed 41.73% to $391.00. The volume of Intercept Pharmaceuticals shares traded was 2251% higher than normal. Citigroup lifted the price target on the stock from $60.00 to $400.00, while Bank of America raised the price target from $81.00 to $872.00.

American Pacific (NASDAQ: APFC) surged 18.97% to $46.54. The volume of American Pacific shares traded was 1202% higher than normal. American Pacific agreed to be acquired by H.I.G. Capital LLC.

Posted-In: volume moversNews Intraday Update Markets Movers

 

Most Popular

Related Articles (APFC + CNAT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free